Pricing Log in Create free account

Acumen Pharmaceuticals, Inc. (ABOS) vs Korro Bio, Inc. (KRRO)

Acumen Pharmaceuticals, Inc. and Korro Bio, Inc. are both Biotechnology companies. Korro Bio, Inc. is the larger, with a market value of $137.1M against $120.8M — 1.1× the size. Across the 12 metrics below, Korro Bio, Inc. leads on 10 and Acumen Pharmaceuticals, Inc. on 2.

Valuation

Metric ABOS KRRO Biotechnology median
P/E n/m n/m 8.42
P/S 84.02 25.66 10.01
P/B 2.11 1.59 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 29.27 10.53 9.41
Earnings yield (97.60%) (107.41%) (31.85%)
Free cash flow yield (76.15%) (41.62%) (24.58%)

Profitability

Metric ABOS KRRO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (120.50%) (97.69%) (56.36%)
Return on assets (72.97%) (62.03%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABOS KRRO Biotechnology median
Revenue growth (TTM) — (81.87%) 6.02%
EPS growth (last fiscal year) (16.96%) (33.19%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABOS KRRO Biotechnology median
Debt to equity 0.55 0.00 0.00
Current ratio 2.47 9.55 4.72
Net debt to EBITDA 0.69 0.64 0.96

Dividend

Metric ABOS KRRO Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ABOS KRRO Biotechnology median
Market cap 120.77m 137.09m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack